Report Queensland Biodiscovery Collaboration The Griffith University AstraZeneca Partnership for Natural Product Discovery An Access & Benefit Sharing Case Study (Jan 2008) | ABSCH-VLR-SCBD-263816 | Ресурс виртуальной библиотеки | Access and Benefit-Sharing Clearing-HouseAccess and Benefit-Sharing Clearing-HouseAccess and Benefit-Sharing Clearing-House/ru/
Срок действия сеанса истек. Срок действия сеанса истек. Выполните вход для продолжения.
Ошибка входа. Введен неверный адрес электронной почты или пароль.
Сбой операции. Служба недоступна. Повторите попытку позже.
Report Queensland Biodiscovery Collaboration The Griffith University AstraZeneca Partnership for Natural Product Discovery An Access & Benefit Sharing Case Study
EN
This report was written by
Sarah Laird, Catherine Monagle, and Sam Johnston.
In 1993, the Australian State of Queensland's Griffith University formed a partnership with Astra Pharmaecuticals to pursue a natural product (NP) drug discovery programme under the banner of the Queensland Pharmaceutical Research Institute (QPRI). This partnership persisted through the merger of Astra Pharmaceuticals with Zeneca to form AstraZeneca AB in 1999. QPRI was renamed AstraZeneca R&D Brisbane, then evolved into the Natural Product Discovery Unit (NPD), and finally moved under the aegis of the Eskitis Institute for Cell and Molecular Therapies
